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Abstract 
Background: Missed appointments are a common problem in health care. No-show rates and incomplete appointments for referred 
patients affect patient outcomes and clinician’s productivity, including comprehensive medication management (CMM) visits that 
pharmacists provide. This study aims to compare CMM completion rates between various intervention types in communicating with 
the patient.  
Methods: This was a prospective, multi-clinic study to examine newly implemented intervention effects on CMM completion rates. The 
primary outcomes were CMM completion rates among newly referred patients and CMM completion rates in any no-show patients, 
including both newly referred and returning patients. In the newly referred patient cohort, three intervention types (blocking time on 
the pharmacist’s schedule to speak to the patient, sending an electronic medical record or EMR-linked message, and sending a letter) 
were compared to a control group with no interventions. In the no-show cohort, a pharmacist call intervention was compared to a 
control group consisting of sending a letter. 
Results: Completed CMM appointment rate was six times likely with a pharmacist’s in-person reminder (odds ratio [OR] 6.0; 95% 
confidence interval [CI] 1.58-22.77) and with an EMR-linked message (OR 6.0; 95% CI 1.76 to 20.52) when compared to sending a letter. 
In no-show patients, completed CMM appointment rate was 2.36 times likely with a pharmacist’s call intervention versus sending a 
letter. 
Conclusion: Pharmacist’s direct reminder to the patient when in clinic and EMR-linked message improved CMM completion rate when 
compared to mailing a reminder letter. Pharmacist’s call to no-show patients for their CMM appointment was effective for the 
patients to reschedule and complete their CMM appointment compared to mailing a reminder letter. 
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Introduction 
Comprehensive medication management (CMM) is a standard 
of care process that ensures each patient’s medications are 
individually assessed during a visit to determine that they are 
appropriate, effective, safe, and able to be taken as intended 
by the prescriber.1 Previous studies and research have shown 
that CMM visits provided by a medication therapy 
management (MTM) pharmacist reduce hospital readmission 
rates by 33%.2 By utilizing a MTM pharmacist, measures 
associated with chronic disease management can be 
improved. In a study looking at the impact of management of 
type 2 diabetes when pharmacists were added to a patient’s 
primary care team, teams with a pharmacist were able to more 
significantly decrease A1c levels compared to teams without a 
pharmacist.3 Assuming that a 1% decrease in A1c correlates 
with a 37% reduction in microvascular complications, the 
pharmacists added to the primary care teams were correlated 
with a 96% decrease in microvascular complications.  
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Additionally, other measures such as lipid levels and blood 
pressure were improved. The MTM pharmacist on the team 
was not only able to improve short-term clinical markers but 
also reduce estimated long-term cardiovascular risk by a 4.5-
fold reduction in estimated 10-year risk of coronary heart 
disease and stroke.3 Improving measures in chronic disease 
management improved both patient’s health outcomes and 
quality measures for the health care team such as STAR 
ratings. 
 
However, missed appointments and incomplete referrals are 
common challenges in health care delivery. An incomplete 
referral occurs when a newly referred patient fails to schedule 
and/or complete the referred visit. No-show rates and 
uncompleted appointments for referrals may be associated 
with negative patient outcomes and clinician productivity. A 
no-show appointment can be defined in a number of different 
ways: a patient that fails to appear, arrives too late for an 
appointment, or cancels with short notice to be able to 
schedule a different patient during their original appointment 
time.5 A number of studies have been conducted on no show 
rates, looking at common reasons for patients missing 
appointments. No show rates vary between practices, 
providers, and a variety of factors have been found to play a 
role in patients not showing up to scheduled appointments. 
Demographic factors associated with higher no-show rates 
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were younger age, lower socioeconomic status, and presence 
of mental health disorders.9 Initial appointments have also 
been found to be more frequently missed than follow-up 
appointments when the patients have not had an established 
relationship with the healthcare provider, were less engaged, 
or did not fully understand the purpose of the clinic 
appointment.9 In a study of 10 primary care and sub-specialty 
clinics over a 12-year period, the average no-show rate for all 
appointments was 18.8%.10  
 
When a specialist referral is made, patients may choose to go 
forward with the referral and complete the visit with the 
specialist or not. Specialist referral completion rates ranged 
from 77 to 83% in the literature.6,7 A variety of factors play a 
role in a patient’s referral completion rate. The two most 
common reasons for incomplete referral in one study were 
found to be “lack of time” and patient belief that the “health 
problem had resolved.” These reasons were mutually 
exclusive.5 One study found that incomplete referrals were 
strongly associated with difficulty getting appointments 
quickly, locating the office, and inconvenient office hours.7 
Another contributing factor for incomplete referral was 
communication between the referring physician and the 
specialist. Referral tracking is an important task to ensure the 
referral was completed but is not always done. 
 
Many different types of intervention strategies have been 
used across different health systems to address no-show 
events. Strategies such as reminder calls or texts, patient 
incentives, penalty fees for no-show, patient education, and 
discharging the patient from clinic, were used to help decrease 
appointment no shows.5 Other strategies such as overbooking 
appointment schedules and same-day/urgent appointments 
were utilized to minimize the impact of no-show rates on the 
clinic.5 Reminder calls and/or texts prior to appointments and 
further patient education have shown promising results in 
improving no-show rates. Probationary measures, such as 
implementing a no-show fee on select patients with multiple 
no-show appointments, have also proven to decrease no-show 
rates.5  
 
Studies have shown that patients with frequent no-show 
appointments were less likely to have adequate preventative 
care, have worse control of chronic illnesses, and have 
increased rates of emergency department visits and 
hospitalizations.5,11,12 In other words, improving completed 
CMM visit rates and reducing no show rates among newly 
referred patients may lead to a greater impact on patient 
outcomes and the health care system’s performance. Under 
the assumption that improving CMM completion rates among 
patients newly referred to CMM services and reschedule rates 
for no-show patients would improve long-term patient 
outcomes, this study was conducted to examine the 
effectiveness of MTM pharmacist’s interventions to reach out 
to no-show patients on overall CMM completion rates. 
 
Methods 
Study Objectives 
The study aims to compare CMM completion rates between 
newly implemented intervention groups within the 
healthcare system to evaluate protocol in two different study 
cohorts: newly referred patient cohort (cohort 1) and no-
show patient cohort (cohort 2). 
 
Practice Setting 
The study was conducted within Fairview Health Services, a 
nonprofit organization and one of the largest health systems 
serving Minnesota. Fairview is a network of 12 hospitals and 
medical centers, 56 primary care clinics, 36 pharmacies, and 
almost 4,000 providers of primary care and specialty care. 
Included within this expanding network is the largest MTM 
program in the state with presence in 45 clinics and consisting 
of 36 clinical MTM pharmacists at the time of the study, 
including three pharmacy residents. There are four 
coordinators on the Fairview MTM team who help manage 
billing, schedules, and referrals. 
 
In the Fairview system, referrals for CMM are often ordered by 
primary care providers, care team members, and pharmacists 
(in inpatient and community pharmacy). These referrals may 
be triggered by the identified need of the patient in the 
clinician visits or by criteria-based alerts, notifying the clinician 
that the patient could benefit from a CMM visit. The best 
practice alert (BPA) system triggers a CMM referral in the 
electronic medical record (EMR) by specific criteria, such as a 
patient’s discharge from the hospital. Providers place CMM 
referrals for a variety of reasons such as patient education, if 
patients have medication questions, or for chronic disease 
management. Fairview pharmacists in the community 
pharmacy locations can also refer patients to CMM such as for 
uncontrolled blood pressure or asthma. 
 
The coordinators have a standard process for contacting 
referred patients. The coordinators call these patients to 
schedule an appointment. A voice message is left if the patient 
does not answer. When the coordinators are unable to reach 
the patient after two attempts, the MTM pharmacist at the 
patient’s clinic and the patient’s healthcare team are notified 
through the EMR. However, follow-up strategies upon the 
notification are not consistent within the system. Some 
pharmacists do not act on the notification at all and some act 
by sending a letter to the patient regarding the referral. Newly 
referred patients that receive no action are referred to as the 
control throughout the study. This project aims to standardize 
these follow-up strategies through the study interventions.  
 
Study Design  
This study was a prospective, observational study conducted 
in multi-clinic within a single healthcare system setting to 
examine newly implemented intervention effects on CMM 
completion rates in two cohorts. The primary outcomes were 
CMM completion rates among newly referred patients (cohort 
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1) and CMM completion rates in any no-show patients, 
including both newly referred and returning patients (cohort 
2). This study utilized EMR chart review to capture all data 
pertaining to CMM referrals, completed CMM visits post 
referral, and scheduled CMM visits yet to be completed. 
Interventions occurred from December 2018 through February 
2019, starting a week post implementation date of the system-
wide standardized intervention protocol. In both cohorts, 
patients were excluded if they received short consultations 
(e.g. medication education visits) rather than a full CMM 
service or passed away during the study period. Figure 1 
summarizes the study design by cohort. 
 
Newly referred patients (cohort 1) 
When the coordinators were unable to reach newly referred 
patients to schedule a CMM appointment, the coordinators 
notified a pharmacist at the patient’s designated Fairview 
clinic through the EMR system. There were 3 interventions: 
pharmacist’s blocked time, EMR-linked message, and sending 
a letter. The coordinators checked when the patient would be 
in the designated clinic and made a 30-minute blocked time on 
the pharmacist’s schedule. The pharmacist was to then 
attempt to speak to the patient during that blocked time to 
either complete a CMM visit or schedule the patient for a CMM 
visit. If a patient was not coming into clinic within the month 
or was unable to have a blocked intervention as described 
above, then a letter intervention could be mailed to the 
patient’s home address or an EMR-linked message 
intervention was sent regarding the referral. The EMR-linked 
message sends a message to the patient regarding the referral. 
A CMM visit was defined to be completed if the CMM 
appointment was scheduled within two months of the 
intervention date and completed by the end of March 2019. 
 
No-show patients (cohort 2) 
When patients did not show up to their CMM appointment 
within the 15 minutes from the appointment time, the 
intervention was a pharmacist’s call to the patient. If time 
allowed, the pharmacist could complete the visit if the patient 
was reached via phone, otherwise reschedule the CMM 
appointment. If the patient was not reached, a voice message 
was left. Patients in the control group received a mailed letter 
without the pharmacist’s call as the standard practice within 
this healthcare system. A CMM visit was deemed to be 
completed if the rescheduled appointment was completed 
within two months of the missed appointment date or 
completed by the end of March 2019. Patients were further 
excluded if a voice message was not left from the pharmacist’s 
call.  
 
Statistical Design and Analysis 
The primary outcomes were CMM completion rates in both 
cohort 1 and 2, and secondary outcomes were CMM 
appointment reschedule rates. In cohort 1, the primary testing 
hypothesis was that CMM completion rates in the newly 
referred patients would differ between intervention and 
control (no intervention) groups, with an exploratory 
hypothesis to identify more effective intervention types. In 
cohort 2, the primary testing hypothesis was that CMM 
completion rates among no-show patients would differ 
between pharmacist’s phone-call intervention and control 
(mailing a letter). 
 
χ2 (chi-square) tests were used to examine associations 
between the measured study outcomes and the comparison 
groups. All reported p-values were 2-sided and considered 
statistically significant at < 0.05. In cohort 1, if statistical 
significance was met to support different CMM completion 
rates by interventions, pairwise comparisons between the 3 
intervention groups and control were then performed by odds 
ratio (OR) to identify more effective intervention types. In 
cohort 2, if there were statistically significant differences in 
CMM completion rates between intervention and control, we 
further investigated CMM completion rates between the call 
intervention statuses: Reached (i.e. a pharmacist spoke with 
the patient) and Not Reached (i.e. a pharmacist left a voice 
message). A binary logit model was fit to examine whether the 
probabilities of CMM completion differed by the intervention 
status. All statistical analyses were performed using SAS 
software (version 9.4; SAS Institute Inc, Cary, NC).  
 
Results 
Completed CMM Visits in cohort 1 
Of the 174 newly referred patients in cohort 1, three were 
further excluded due to receiving more than one intervention. 
Of the remaining 171 patients, 15 received a block 
intervention, 20 received an EMR-linked message 
intervention, 60 received a letter intervention, and 76 received 
no intervention (control). Overall, 34 (19.9%) of the 171 newly 
referred patients completed the CMM visit. The CMM 
completion rates differed between the intervention groups. 
Six (40%), 8 (40%), 7(10.7%), and 14 (18.4%) patients 
completed their CMM visit in block, EMR-linked message, 
letter, and control groups, respectively (P=0.0104). From 
pairwise comparisons between the intervention groups, 
patients in the block and EMR-linked message intervention 
groups were six times likely to complete a CMM visit compared 
to sending a letter. The odds ratio (OR) was 6.0 (95% 
confidence interval [CI] 1.58-22.77) with block intervention 
and OR was 6.0 (95% CI 1.76 -20.52) with an EMR-linked 
message intervention. There were no statistically significant 
differences in CMM completion rates between sending a letter 
versus control or between block and EMR-linked message. The 
pairwise comparisons in OR are summarized in Table 2.  
 
Completed CMM Visits in cohort 2 
Among patients with a no-show appointment in cohort 2, 152 
patients received a phone call from the pharmacist as the 
intervention and 71 patients received a mailed letter (control). 
Overall, 73 (48%) of no-show patients who received a 
pharmacist’s call completed a CMM visit, whereas 20 (28%) of 
no-show patients receiving a letter (control) completed a visit. 
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The CMM completion rate among no-show patients who 
received a pharmacist’s call was 2.36 times the CMM 
completion rate of no-show patients without the call 
intervention (OR 2.36; 95% CI, 1.28-4.32; P=0.0057). 
 
We further categorized the phone call intervention group into 
two intervention statuses: Reached, which was a subset of 
patients in the call intervention group that the pharmacist 
spoke directly via phone and Not Reached, the other subset of 
patients that the pharmacist left a voice message. Of 152 
patients who received the pharmacist call after missing the 
CMM appointment, 57 (37.5%) were Reached and 95 (62.5%) 
were Not Reached. The CMM completion rate was higher in 
Reached than in Not Reached with 63% and 39% CMM 
completion rates, respectively (P=0.0043). There was no 
significant difference in CMM completion rate between Not 
Reached and control. See Table 3. The CMM completion rate 
in Reached patients was 4.37 times the completion rate in 
patients without the call intervention (OR 4.37, 95% CI 2.07-
9.22). 
 
As secondary outcomes, CMM reschedule rates were also 
examined. Overall, 90 (59%) of no-show patients who received 
a pharmacist’s call rescheduled the CMM visit, whereas 29 
(41%) of no-show patients with a mailed letter rescheduled. By 
intervention statuses, of those that were reached, 50 (88%) 
rescheduled the CMM visit compared to 40 (42%) who were 
left with a voice message rescheduled. There was a statistically 
significant difference in reschedule rates between the 
pharmacist’s call intervention and control (P=0.0104). As 
exploratory analysis, 17 of 90 rescheduled patients in the 
intervention group missed their rescheduled appointment 
(18.9% second-time no-show rate), and 9 of 29 rescheduled 
patients in the control group missed their rescheduled 
appointment (31% second-time no-show rate). However, this 
difference in these subsequent no-show rates were not 
statistically significant (P=0.168). 
 
Discussion 
In the newly referred patient cohort, block intervention and 
EMR-linked messaging were more effective when compared to 
sending a referral letter. As technology is further incorporated 
into healthcare, the argument may be made that patients want 
healthcare technology updated and easily accessible in 
mechanisms such as EMR-linked messaging systems. This 
study may provide some premise to say that patients are more 
engaged if online tools such as EMR-linked messages are made 
available and utilized for patients. Additionally, blocking time 
on a pharmacist’s schedule as an intervention can be 
challenging to arrange for the healthcare team and pharmacist 
because it depends on pharmacists’ availabilities during the 
patient’s clinic visit, and patients may not have a scheduled 
visit within the 1-month time window. Such challenge is 
evident in this study as there were only 15 block interventions. 
Blocking time to remind patients to make a referral 
appointment may be time constrained to provide on a regular 
basis and possibly lead to decreased productivity. EMR-linked 
messaging can be explored further as an efficient 
interventional approach. 
 
Based on literature review to the authors’ knowledge, this 
study is the first to look at CMM completion rates in newly 
referred patients and in patients after missing a scheduled 
CMM appointment in a clinic setting. In general, studies 
involving CMM specific referrals and completion rates are 
scarce. In existing literature, many have investigated into 
perceptions on other specialty practice referrals and reasons 
for patients not completing a referral. Studies on CMM 
practice are limited to implementing a referral program or 
increasing the number of referrals but not on improving the 
completed visit rates from already obtained referrals.13,14 
Many of the studies available on CMM visits are also currently 
in the community pharmacy rather than a clinic setting. This 
may be due to varying definitions of a CMM practice in 
different geographical areas and are not all equivalent to the 
services provided to patients in this study. 
 
There are a few study limitations to note. First, there was an 
imbalance in intervention group sizes, which may have led to 
wide 95% confidence intervals in the pairwise comparisons 
with ‘block’ and ‘EMR-linked message’ interventions. 
However, all statistical assumptions of chi-square testing were 
met, and therefore the observed differences in CMM 
completion rates are statistically valid. A potential 
misclassification of intervention groups may exist; the 
intervention groups were determined solely by the EMR 
documentation. Some patients may have received a form of 
intervention but were misclassified as no intervention if such 
intervention was not documented properly in the EMR. This 
may explain the higher CMM completion rate in the no 
intervention group compared to the letter intervention group, 
as it’s less traceable in the EMR than blocks and EMR-linked 
messages. There may be potential unmeasured selection bias 
in the EMR-linked message group as having an activated EMR-
linked patient account may pose a sample selection bias as 
they may be more engaged in their healthcare compared to 
those that do not have it activated. Additionally, preferences 
in intervention choices between EMR-linked message and 
letter may differ among pharmacists. The overall percent of 
activated EMR-linked patient account, account utilization 
levels (e.g. recent log-in time), and patient characteristics 
among those with activated EMR-linked messages were not 
measured and remain unknown in the study population as 
those were beyond the scope of this project. There may be 
additional limitations by varying levels of compliance to the 
intervention protocol by pharmacists and practice settings.  
 
Although patient characteristics were not measured in this 
study, the cohort eligibility was through a standardized referral 
process within the healthcare system. The study objective was 
to examine the effects of pharmacist’s intervention on CMM 
completion rates, and the findings show rather clear 
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differences, especially with more personalized reminder 
approaches such as blocking time, EMR-linked message, and 
following up via phone. Therefore, this study provides relevant 
new information to guide further considerations for protocol 
development and future study directions, such as cost 
effectiveness analysis from the healthcare system’s 
perspectives in operational costs including pharmacist’s 
productivity, CMM completion rates, and patient outcomes.  
 
Conclusion  
This study provides supportive evidence that pharmacist’s 
intervention is associated with higher CMM completion in 
patients who have not scheduled their CMM referral visit or 
did not show up to their scheduled CMM visit. In the newly 
referred patient cohort, CMM completion rates were higher 
with pharmacist’s direct reminder to the patient when in clinic 
and EMR-linked message, when compared to mailing a 
reminder letter or no intervention; both direct in-person 
reminders and EMR-linked messages were similar. In the no-
show patient cohort, a pharmacist’s call to patients had higher 
CMM completion rates compared to mailing a reminder letter.   
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Figure 1a. Newly Referred Patients Cohort Protocol 
 
 
 
 
 
 
Comparison Groups 
Interventions Block time 
EMR-linked message 
Letter 
Control No intervention 
 
 
 
 
 
 
Figure 1b. No-Show Cohort Protocol 
 
 
 
 
 
Comparison Groups 
Intervention Pharmacist phone call 
- Reached 
- Not Reached 
Control Letter 
 
 
 
 
 
 
 
 
 
 
 
Coordinators unable 
to schedule patient 
initially
Block time on 
pharmacist schedule 
if available and 
patient coming to 
clinic within 1 month
If unable to block 
time, pharmacist to 
send EMR-linked 
message or a letter
Patient does not show 
up for CMM visit
Pharmacist calls patient 
15 minutes after visit 
start time to reschedule 
or complete visit via 
phone
Pharmacist leaves a 
voicemail if patient 
does not answer
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Table 1. CMM completion by intervention 
Intervention Type CMM completion 
Yes No 
Block (n=15) 6 (40.0%) 9 (60.0%) 
EMR-linked message (n=20) 8 (40.0%) 12 (60.0%)  
Letter (n=60) 7 (10.2%)  53 (89.8%) 
No intervention (n=76) 14 (18.4%) 62 (81.6%) 
 
 
 
 
Table 2.  Pairwise comparisons between interventions in CMM completion rates in cohort 1 
 Odds Ratio 95% CI 
Block vs EMR-linked message 1.00 0.26 - 3.92 
Block vs Letter 6.00 1.58 - 22.70 
Block vs No intervention 2.95 0.90 - 9.65 
EMR-linked message vs Letter 6.00 1.76 - 20.52 
EMR-linked message vs No intervention 2.95 1.02 - 8.57 
Letter vs No intervention 0.49 0.18 - 1.37 
 
 
 
 
Table 3. Predicted probabilities for CMM completion by intervention status in cohort 2 
  Predicted probability 95% CI 
Call- Reached (n=57) 0.63 0.50 0.74 
Call- Not Reached (n=95) 0.39 0.21 0.49 
Letter (n=71) 0.28 0.19 0.40 
 
 
 
 
Table 4. Predicted probabilities for CMM reschedule by intervention status in cohort 2 
  Predicted probability 95% CI 
Call- Reached (n=57) 0.88 0.76 0.94 
Call- Not Reached (n=95) 0.42 0.33 0.52 
Letter (n=71) 0.41 0.30 0.53 
 
 
 
 
 
 
 
 
 
 
